Anacor Pharmaceuticals, Inc. 4
4 · Anacor Pharmaceuticals, Inc. · Filed Jan 25, 2016
Insider Transaction Report
Form 4
Zane Lee
VP, Clinical Dev & Interim CMO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2016-01-22−11,800→ 0 totalExercise: $7.55Exp: 2020-08-20→ Common Stock (11,800 underlying) - Exercise/Conversion
Common Stock
2016-01-22$7.55/sh+11,800$89,090→ 39,081 total
Footnotes (1)
- [F1]This option is fully vested and exercisable.